Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lajos Kemény, Lovisa Berggren, Martin Dossenbach, Yves Dutronc & Carle Paul. (2019) Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3. Journal of Dermatological Treatment 30:1, pages 19-26.
Read now
Read now
April Armstrong, Luis Puig, Richard Langley, Tsen Fang Tsai, Michael Song, Yasmine Wasfi, Jingzhi Jiang, Shu Li & Chenglong Han. (2019) Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial. Journal of Dermatological Treatment 30:1, pages 27-34.
Read now
Read now
Charles L Thomas & Andrew Y Finlay. (2006) Measuring the effects of psoriasis on quality of life. Expert Review of Dermatology 1:5, pages 723-736.
Read now
Read now
Drew W Miller & Steven R Feldman. (2006) Cost-effectiveness of moderate-to-severe psoriasis treatment. Expert Opinion on Pharmacotherapy 7:2, pages 157-167.
Read now
Read now
Articles from other publishers (64)
Khalid M. Mohany, Sherouk Elkady, Eman M. Kamal Youssef, Noorhan M. Sayed & Naglaa Kamal Idriss. (2023) Pigment epithelium-derived factor (PEDF) represses the glucose transporter 1 (GLUT1) mRNA expression and may be a potential therapeutic agent in psoriasis: a case–control and experimental study. Scientific Reports 13:1.
Crossref
Crossref
Rochelle L. Castillo, Ikjot Sidhu, Igor Dolgalev, Tinyi ChuAleksandr Prystupa, Ipsita Subudhi, Di Yan, Piotr Konieczny, Brandon Hsieh, Rebecca H. Haberman, Shanmugapriya Selvaraj, Tomoe Shiomi, Rhina MedinaParvathy Vasudevanpillai GirijaAdriana Heguy, Cynthia A. LoomisLuis Chiriboga, Christopher Ritchlin, Maria De La Luz Garcia-Hernandez, John Carucci, Shane A. MeehanAndrea L. NeimannJohann E. Gudjonsson, Jose U. Scher & Shruti Naik. (2023) Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems. Science Immunology 8:84.
Crossref
Crossref
Ghulam Hassan Bhat, Sadaf Guldin, Mosin Saleem Khan, Mir Yasir & Ganesh Prasad. (2022) Vitamin D status in Psoriasis: impact and clinical correlations. BMC Nutrition 8:1.
Crossref
Crossref
Eleftheria Tampouratzi, Markos Papakonstantis, John Katsantonis, Theodoros Sidiropoulos, Florentina Delli, Konstantinos Efthymiadis, Konstantinos Sfaelos, Athina Christodoulou, Vasiliki Chasapi & Pantelis Panagakis. (2022) Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals. Dermatologic Therapy 35:7.
Crossref
Crossref
Vikram K. Mahajan, Narvir S. Chauhan, Baldev S. Rana, Karaninder S. Mehta, Sheenam Hooda, Pushpinder S. Chauhan & Amisha Kukreja. (2022) The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study. Journal of Clinical and Experimental Hepatology 12:3, pages 785-792.
Crossref
Crossref
Robert Jeffrey Edwards, Leon Omari Lavia, Jonathan Edwards & Gregory Boyce. (2022) Psoriasis in Patients Attending a Large HIV Clinic in Trinidad. Medical Sciences 10:1, pages 9.
Crossref
Crossref
Sat Byul Park, Kwang Min Kim, Bom Taeck Kim, Nam Seok Joo & Kyu Nam Kim. (2021) Nutritional treatment for psoriasis: A case report. Advances in Integrative Medicine 8:3, pages 240-243.
Crossref
Crossref
Richard B. Warren, Alice B. Gottlieb, Joseph F. Merola, Llenalia Garcia, Christopher Cioffi, Luke Peterson, Christopher Pelligra & Valerie Ciaravino. (2021) Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials. Dermatology and Therapy.
Crossref
Crossref
Ashwani Rana, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan, Mukul Kumar, Anuj Sharma, Reena Sharma, Niharika Dhattarwal & Megha Sondhi. (2020) Cardiomyopathy and echocardiographic abnormalities in Indian patients with psoriasis: Results of a pilot study. International Journal of Clinical Practice 75:3.
Crossref
Crossref
VikramK Mahajan, Niharika Dhattarwal, PushpinderS Chauhan, KaraninderS Mehta, Reena Sharma, Anuj Sharma, VijayK Singh, Jyotshna Sharma & Sheenam Hooda. (2021) The association of alcohol use disorder and chronic plaque psoriasis: Results of a pilot study. Indian Dermatology Online Journal 12:1, pages 128.
Crossref
Crossref
Mohammad Ali Shatalebi, Safoura Bokaie Jazi, Afsaneh Yegdaneh, Fariba Iraji, Amir Hossein Siadat & Pegah Noorshargh. (2020) Comparative evaluation of Gracilaria algae 3% cream vs Clobetasol 0.05% cream in treatment of plaque type psoriasis: A randomized, split‐body, triple‐blinded clinical trial. Dermatologic Therapy 33:6.
Crossref
Crossref
Shamim Ara, Mohammad Rafiqul Mowla, Mansurul Alam & Ismail Khan. (2020) Efficacy of oral methotrexate (MTX) monotherapy vs oral MTX plus narrowband ultraviolet light B phototherapy in palmoplantar psoriasis. Dermatologic Therapy 33:4.
Crossref
Crossref
Dylan Haynes, Jennifer L. Strunck, Christina A. Topham, Alex G. Ortega-Loayza, Gail Kent, Pamela B. Cassidy, Ronghua Hu, Keith Choate, Zhiping Wang, Yuangang Liu & Teri M. Greiling. (2020) Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris. JAMA Dermatology 156:6, pages 668.
Crossref
Crossref
Ashwani Rana, VikramK Mahajan, PushpinderS Chauhan, KaraninderS Mehta, SatyaBhushan Sharma, Anuj Sharma & Reena Sharma. (2020) The association of thyroid dysfunction with chronic plaque psoriasis: A hospital-based retrospective descriptive observational study. Indian Dermatology Online Journal 11:5, pages 771.
Crossref
Crossref
Leena Chularojanamontri, Chanisada Wongpraparut, Waranaree Winayanuwattikun, Chris E. M. Griffiths & Robert J. G. Chalmers. (2019) A Reevaluation of the Simplified Psoriasis Index (SPI) Using the Thai Language Version: A Study Examining the Validity, Reliability, and Interpretability of SPI When Used in Translation. Journal of Psoriasis and Psoriatic Arthritis 5:1, pages 32-39.
Crossref
Crossref
M.A. Richard, S. Aractingi, P. Joly, E. Mahé, P. Auquier, S. Le Guen, C. Acquadro, F. Boucher & R.J.G. Chalmers. (2019) Adaptation française d’un nouveau score destiné à l’évaluation globale de la sévérité du psoriasis : l’Indice Simplifié du Psoriasis (Simplified Psoriasis Index, SPI). Annales de Dermatologie et de Vénéréologie 146:12, pages 783-792.
Crossref
Crossref
Payvand Kamrani, Arjun M. Bashyam & Steven R. Feldman. (2019) Review of Outcome Measures in Trials and Practice for Psoriasis. Current Dermatology Reports 8:4, pages 313-318.
Crossref
Crossref
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan-Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette Siaton, Benjamin J. Smith, Abby S. Van Voorhees, Anna Helena Jonsson, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana-Maria Orbai, Soumya M. Reddy, Jose U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner & James Reston. (2018) 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis 4:1, pages 31-58.
Crossref
Crossref
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette Siaton, Benjamin J. Smith, Abby S. Van Voorhees, Anna Helena Jonsson, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, Jose U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner & James Reston. (2018) 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis & Rheumatology 71:1, pages 5-32.
Crossref
Crossref
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette Siaton, Benjamin J. Smith, Abby S. Van Voorhees, Anna Helena Jonsson, Amit Aakash Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, Jose U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner & James Reston. (2018) 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care & Research 71:1, pages 2-29.
Crossref
Crossref
R.J.G. Chalmers. (2018) Documenting and defining psoriasis severity: an ongoing challenge. British Journal of Dermatology 179:6, pages 1244-1245.
Crossref
Crossref
A.B. KimballM. Augustin, K.B. GordonG.G. KruegerD. PariserS. FakharzadehK. GoyalS. CalabroS. LeeR. LinN. LiB. SrivastavaL. Guenther. (2018) Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). British Journal of Dermatology 179:4, pages 984-986.
Crossref
Crossref
Anca Chiriac, Cristian Podoleanu & Doina Azoicai. 2017. An Interdisciplinary Approach to Psoriasis. An Interdisciplinary Approach to Psoriasis.
Carlo Salvarani, Giampiero Girolomoni, Vito Di Lernia, Paolo Gisondi, Giovanni Tripepi, Colin Gerard Egan & Antonio Marchesoni. (2016) Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis. Seminars in Arthritis and Rheumatism 46:3, pages 305-311.
Crossref
Crossref
Jaehwan Kim, Robert Bissonnette, Jongmi Lee, Joel Correa da Rosa, Mayte Suárez-Fariñas, Michelle A. Lowes & James G. Krueger. (2016) The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes. Journal of Investigative Dermatology 136:11, pages 2173-2182.
Crossref
Crossref
Jaehwan Kim, Chil-Hwan Oh, Jiehyun Jeon, Yoosang Baek, Jaewoo Ahn, Dong Joo Kim, Hyun-Soo Lee, Joel Correa da Rosa, Mayte Suárez-Fariñas, Michelle A. Lowes & James G. Krueger. (2016) Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets. Journal of Investigative Dermatology 136:1, pages 161-172.
Crossref
Crossref
ANG PENG WONG, TATIANA KALINOVSKY, ALEKSANDRA NIEDZWIECKI & MATTHIAS RATH. (2015) Efficacy of nutritional treatment in patients with psoriasis: A case report. Experimental and Therapeutic Medicine 10:3, pages 1071-1073.
Crossref
Crossref
C. Chow, M.J. Simpson, T.A. Luger, H. Chubb & C.N. Ellis. (2015) Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment. Journal of the European Academy of Dermatology and Venereology 29:7, pages 1406-1414.
Crossref
Crossref
Joanna Bartosińska, Anna Michalak-Stoma, Maria Juszkiewicz-Borowiec, Małgorzata Kowal & Grażyna Chodorowska. (2015) The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. Mediators of Inflammation 2015, pages 1-8.
Crossref
Crossref
Robert J.G. Chalmers. (2015) Assessing Psoriasis Severity and Outcomes for Clinical Trials and Routine Clinical Practice. Dermatologic Clinics 33:1, pages 57-71.
Crossref
Crossref
Y. Meng, L. Dongmei, P. Yanbin, F. Jinju, T. Meile, L. Binzhu, H. Xiao, T. Ping & L. Jianmin. (2014) Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clinical and Experimental Dermatology 39:6, pages 696-707.
Crossref
Crossref
Leena Chularojanamontri, Christopher E.M. Griffiths & Robert J.G. Chalmers. (2013) The Simplified Psoriasis Index (SPI): A Practical Tool for Assessing Psoriasis. Journal of Investigative Dermatology 133:8, pages 1956-1962.
Crossref
Crossref
Viviana Lora, Chiara Bonaguri, Paolo Gisondi, Franca Sandei, Luisita Battistelli, Annalisa Russo, Alessandra Melegari, Tommaso Trenti, Giuseppe Lippi & Giampiero Girolomoni. (2013) Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunologic Research 56:2-3, pages 382-389.
Crossref
Crossref
P. Gisondi, V. Lora, C. Bonauguri, A. Russo, G. Lippi & G. Girolomoni. (2013) Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. British Journal of Dermatology 168:4, pages 749-755.
Crossref
Crossref
J. Bostoen, S. Bracke, S. De Keyser & J. Lambert. (2012) An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial. British Journal of Dermatology 167:5, pages 1025-1031.
Crossref
Crossref
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof & Alexa Boer Kimball. (2012) Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design. Clinical Investigation 2:7, pages 671-678.
Crossref
Crossref
J. H. Kim, B. Y. Kim, J. W. Choi, S. O. Kim, H. S. Lee, K. C. Park & S. W. Youn. (2011) The objective evaluation of the severity of psoriatic scales with desquamation collecting tapes and image analysis. Skin Research and Technology 18:2, pages 143-150.
Crossref
Crossref
Sinéad M. Langan, Nicole M. Seminara, Daniel B. Shin, Andrea B. Troxel, Stephen E. Kimmel, Nehal N. Mehta, David J. Margolis & Joel M. Gelfand. (2012) Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom. Journal of Investigative Dermatology 132:3, pages 556-562.
Crossref
Crossref
Julia Frühauf & Rainer Hofmann-Wellenhof. 2012. Telemedicine in Dermatology. Telemedicine in Dermatology
103
112
.
Kim A. Papp, James Signorovitch, Karthik Ramakrishnan, Andrew P. Yu, Shiraz R. Gupta, Yanjun Bao & Parvez M. Mulani. (2011) Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life. Clinical Drug Investigation 31:1, pages 51-60.
Crossref
Crossref
Wolfgang HueberDhavalkumar D. PatelThaddeus DryjaAndrew M. WrightIrina KorolevaGerard BruinChristian AntoniZoe DraelosMichael H. GoldPatrick DurezPaul P. TakJuan J. Gomez-ReinoC. Stephen FosterRosa Y. KimC. Michael SamsonNaomi S. FalkDavid S. ChuDavid CallananQuan Dong NguyenKristine RoseAsifa HaiderFranco Di Padova. (2010) Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis. Science Translational Medicine 2:52.
Crossref
Crossref
D. Colombo, N. Cassano, G. Altomare, A. Giannetti & G.A. Vena. (2010) Psoriasis Relapse Evaluation with Week-End Cyclosporine a Treatment: Results of a Randomized, Double-Blind, Multicenter Study. International Journal of Immunopathology and Pharmacology 23:4, pages 1143-1152.
Crossref
Crossref
Phyllis I. Spuls, Lidian L.A. Lecluse, Marie-Louise N.F. Poulsen, Jan D. Bos, Robert S. Stern & Tamar Nijsten. (2010) How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review. Journal of Investigative Dermatology 130:4, pages 933-943.
Crossref
Crossref
Luigi Naldi. (2010) Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clinics in Dermatology 28:1, pages 67-72.
Crossref
Crossref
Stefan Kazimierz Piechnik, Karin Øien Forseth & Anne-Lene Krogstad. (2009) Semi-quantitative assessment of the distribution of skin lesions in patients with psoriasis and psoriasis arthritis. Skin Research and Technology 15:4, pages 451-458.
Crossref
Crossref
Vinod Chandran, Alice Gottlieb, Richard J. Cook, Kristina Callis Duffin, Amit Garg, Philip Helliwell, Arthur Kavanaugh, Gerald G. Krueger, Richard G. Langley, Charles Lynde, Neil McHugh, Philip Mease, Ignazio Olivieri, Proton Rahman, Cheryl F. Rosen, Carlo Salvarani, Diamant Thaci, Sergio M. A. Toloza, Maxine Yat Wing Wong, Qian M. Zhou & Dafna D. Gladman. (2009) International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Care & Research 61:9, pages 1235-1242.
Crossref
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Consensus Document on the Evaluation and Treatment of Moderate to Severe Psoriasis. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliográficas (English Edition) 100:4, pages 277-288.
Crossref
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Documento de consenso sobre la evaluación y el tratamiento de la psoriasis moderada/grave del Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Actas Dermo-Sifiliográficas 100:4, pages 277-286.
Crossref
Crossref
J. Schmitt, Z. Zhang, G. Wozel, M. Meurer & W. Kirch. (2008) Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. British Journal of Dermatology 159:3, pages 513-526.
Crossref
Crossref
J.M. Carrascosa. (2008) Estrategias para optimizar el tratamiento con efalizumab. Actas Dermo-Sifiliográficas 99, pages 37-50.
Crossref
Crossref
Jochen Schmitt & Daniel E. Ford. (2007) Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approach. General Hospital Psychiatry 29:2, pages 134-140.
Crossref
Crossref
Leszek Markuszeski, Andrzej Bissinger, Iwo Janusz, Joanna Narbutt, Anna Sysa Jedrzejowska & Anna Zalewska. (2007) Heart Rate and Arrhythmia in Patients with Psoriasis Vulgaris. Archives of Medical Research 38:1, pages 64-69.
Crossref
Crossref
J. Berth-Jones, K. Grotzinger, C. Rainville, B. Pham, J. Huang, S. Daly, M. Herdman, P. Firth & K. Hotchkiss. (2006) A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. British Journal of Dermatology 155:4, pages 707-713.
Crossref
Crossref
Giancarlo Maria Liumbruno, Paolo Emilio Centoni, Pietra Molfettini, Silvia Ceretelli, Massimo Ceccarini, Laura Bachini, Adriano Pomponi, Giovanni Bagnoni, Margherita Vitolo, Olimpia Eberle, Alessandro Biondi & Maria Laura Sodini. (2006) Lymphocytapheresis in the treatment of psoriasis vulgaris. Journal of Clinical Apheresis 21:3, pages 158-164.
Crossref
Crossref
P. Humbert. (2005) Les critères de sévérité du psoriasis. Annales de Dermatologie et de Vénéréologie 132:8-9, pages 4-5.
Crossref
Crossref
Karin Berger, Birgit Ehlken, Barbara Kugland & Matthias Augustin. (2005) Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. Krankheitskosten bei Patienten mit mittelschwerer und schwerer chronischer Psoriasis vulgaris in Deutschland. Journal der Deutschen Dermatologischen Gesellschaft 3:7, pages 511-518.
Crossref
Crossref
R.P. Katugampola, Y. Hongbo & A.Y. Finlay. (2005) Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. British Journal of Dermatology 152:6, pages 1256-1262.
Crossref
Crossref
A.Y. Finlay. (2005) Current severe psoriasis and the Rule of Tens. British Journal of Dermatology 152:5, pages 861-867.
Crossref
Crossref
P. C. M. van de Kerkhof. (2005) The topical treatment of psoriasis. Clinical and Experimental Dermatology 30:2, pages 205-208.
Crossref
Crossref
Toni M Dando & Keri Wellington. (2005) Topical Tazarotene. American Journal of Clinical Dermatology 6:4, pages 255-272.
Crossref
Crossref
Lyn Guenther, Richard G. Langley, Neil H. Shear, Robert Bissonnette, Vincent Ho, Charles Lynde, Eileen Murray, Kim Papp, Yves Poulin & Catherine Zip. (2005) Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel. Journal of Cutaneous Medicine and Surgery 8:5, pages 321-337.
Crossref
Crossref
Lyn Guenther, Richard G Langley, Neil H. Shear, Robert Bissonnette, Vincent Ho, Charles Lynde, Eileen Murray, Kim Papp, Yves Poulin & Catherine Zip. (2016) Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel. Journal of Cutaneous Medicine and Surgery 8:5, pages 321-337.
Crossref
Crossref
Aldona Pietrzak, Ewa Dybiec, Janusz Urban & Grażyna Chodorowska. (2004) Sonographic assessment of the liver in children with psoriasis. Journal of Clinical Ultrasound 32:7, pages 344-347.
Crossref
Crossref
Caroline Fenton & Greg L Plosker. (2004) Calcipotriol/Betamethasone Dipropionate. American Journal of Clinical Dermatology 5:6, pages 463-478.
Crossref
Crossref